Stock Research: Redcare Pharmacy

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Redcare Pharmacy

XTRA:RDC NL0012044747
21
  • Value
    54
  • Growth
    47
  • Safety
    Safety
    6
  • Combined
    17
  • Sentiment
    49
  • 360° View
    360° View
    21
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Redcare Pharmacy NV is an online retailer of pharmaceutical products. The company focuses on non-prescription medication (OTC), and pharmacy-related beauty and personal care (BPC) products. It operates in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany. In the last fiscal year, the company had $2,189 million market cap, $565 million profits, $2,454 million revenue and 2659 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 21 (better than 21% compared with alternatives), overall professional sentiment and financial characteristics for the stock Redcare Pharmacy are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Redcare Pharmacy. The only rank that is above average is the consolidated Safety Rank at 54, which means that the company has a financing structure that is safer than those of 54% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 6, which means that the share price of Redcare Pharmacy is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 47, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 49, which means that professional investors are more pessimistic about the stock than for 51% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
Sound Pay Europe
MDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 4-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 8 8 25
Growth
47 59 100 31
Safety
Safety
54 40 29 82
Sentiment
49 49 55 71
360° View
360° View
21 56 48 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
66 49 56 48
Opinions Change
60 46 50 58
Pro Holdings
n/a 18 8 32
Market Pulse
62 75 87 90
Sentiment
49 49 55 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 8 8 25
Growth
47 59 100 31
Safety Safety
54 40 29 82
Combined
17 46 32 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 1 12 2
Price vs. Earnings (P/E)
39 16 15 28
Price vs. Book (P/B)
16 10 12 31
Dividend Yield
1 1 1 1
Value
6 8 8 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
96 98 98 76
Profit Growth
72 4 84 13
Capital Growth
4 72 85 33
Stock Returns
18 33 100 39
Growth
47 59 100 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
69 68 63 94
Refinancing
75 51 48 73
Liquidity
10 89 14 36
Safety Safety
54 40 29 82

Similar Stocks

Discover high‑ranked alternatives to Redcare Pharmacy and broaden your portfolio horizons.

Koninklijke BAM Groep

ENXTAM:BAMNB
Country: Netherlands
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Dino Polska

WSE:DNP
Country: Poland
Industry: Food Retail
Size: Large
Full Stock Analysis

Carrefour

ENXTPA:CA
Country: France
Industry: Hypermarkets, Super Centers
Size: XX-Large
Full Stock Analysis

Sonae

ENXTLS:SON
Country: Portugal
Industry: Food Retail
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.